RedHill Biopharma Announces Q1/2023 Financial Results and Operational Highlights
Q1/23 Talicia net revenues of $3.4 million; Cash balance of $28.8 million as of March 31, 2023[1]; Extinguishment of all debt obligations in exchange for the...
Stay updated with breaking news from Dror Ben Asher. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Q1/23 Talicia net revenues of $3.4 million; Cash balance of $28.8 million as of March 31, 2023[1]; Extinguishment of all debt obligations in exchange for the...
Having extinguished all debt and significantly reduced cost-base, RedHill is now focused on late-stage pipeline advancement, in collaboration with U.S. and...
The National Institutes of Health's (NIH) Radiation and Nuclear Countermeasures Program (RNCP) has selected opaganib for testing via their radiation medical...
Investegate announcements from RedHill Biopharma, RDHL Opaganib Selected by NIH RNCP For Development
Non-binding agreement in principle reached with HCR on sale of Movantik to extinguish all debt obligations, to facilitate growth Q3/22 Net revenues of $17.6...